[New developments in the treatment of inflammatory bowel diseases. What is certain?].
Feurle
G E
GE
D000636:Aminosalicylic Acids / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D003424:Crohn Disease / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D019804:Mesalamine; D008795:Metronidazole / Q000627:therapeutic use; D012460:Sulfasalazine / Q000627:therapeutic use
D000636:Aminosalicylic Acids; D007166:Immunosuppressive Agents; D008795:Metronidazole; D012460:Sulfasalazine; D019804:Mesalamine
Neue Entwicklungen in der Therapie entzündlicher Darmerkrankungen. Was ist gesichert?